VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES | Patent Publication Number 20230285548

US 20230285548 A1
Patent Number-
Application Number18080639
Filled DateDec 13, 2022
Priority DateDec 16, 2021
Publication DateSep 14, 2023
Original Assignee
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsPatrick WILKINSON
Manuel Alejandro Sepulveda
Derick Siegel
Charles George Drake
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.